Differential changes in deep and cortical gray matters of patients with multiple sclerosis: A quantitative magnetic resonance imaging study

Journal of Computer Assisted Tomography

Volumn 34, Issue 3, 2010, Pages 431-436

  Zhou, Fuqing ^a,b   Zee, Chi Shing ^b   Gong, Honghan ^a   Shiroishi, Mark ^b   Li, Jiaping ^c  

^a NANCHANG UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diffusion tensor imaging; Fractional anisotropy; Multiple sclerosis; Normal appearing gray matter

Indexed keywords

ANISOTROPY; DIFFUSION; DIFFUSION TENSOR IMAGING; MAGNETIC RESONANCE IMAGING; SILICON COMPOUNDS; TENSORS;

CORTICAL GREY MATTER; DIFFUSION TENSOR; FRACTIONAL ANISOTROPY; GRAY MATTER; INTENSITY VALUES; LESION VOLUME; MEAN DIFFUSIVITY; MULTIPLE SCLEROSIS; NORMAL-APPEARING GRAY MATTER; SIGNAL INTENSITIES;

BRAIN;

ANALYSIS OF VARIANCE; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; FRONTAL LOBE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL PROCESSING; TEMPORAL LOBE; THALAMUS;

EID: 77952991387     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181cbf73c     Document Type: Article

References (25)

1. Pirko I, Lucchinetti CF, Sriram S, et al. Gray matter involvement in multiple sclerosis. Neurology. 2007;68:634-642.
2. Geurts J J G, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol. 2008;7:841-851.
3. Ceccarelli A, Filippi M, Neema M, et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult Scler. 2009;15:678-686.
4. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121-127.
5. Bakshi R, Benedict RH, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol. 2002;59:62-68.
6. Anderson VM, Fox NC, Miller DH. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging. 2006;23:605-618.
7. Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol. 1997;244:266-270.
8. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1962;25:315-320.
9. Geurts JJ, Pouwels PJ, Uitdehaag BM, et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology. 2005;236:254-260.
10. Charil A, Dagher A, Lerch JP, et al. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage. 2007;34:509-517.
11. Brass SD, Benedict R H B, Weinstock-Guttman B, et al. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler. 2006;12:437-444.
12. Zivadinov R, Minagar A. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach. J Neurol Sci. 2009;282:1-4.
13. Amato MP, Portaccio E, Goretti B, et al. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol. 2007;64:1157-1161.
14. Benedict RH, Weinstock-Guttman B, Fishman I, et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol. 2004;61:226-230.
15. Bozzali M, Cercignani M, Sormani MP, et al. Quantification of brain gray matter damage in different MS phenotypes using diffusion tensor MR imaging. Am J Neuroradiol. 2002;23:985-988. (Pubitemid 34663445)
16. Vrenken H, Pouwels PJ, Geurts JJ, et al. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging. 2006;23:628-636.
17. Haackea EM, Mittalc S, Wue Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, Part 1. Am. J. Neuroradiol. 2009;30:19-30.
18. Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging. 2009;29:537-544.
19. Sailer M, Fischl B, Salat D, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain. 2003;126:1734-1744. (Pubitemid 36917333)
20. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23:1-25.
21. Neema M, Arora A, Healy BC, et al. Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging. 2009;19:3-8.
22. Pirko I, Johnson A, Lohrey A, et al. Deep gray matter T2 hypointensity correlates with disability in a murine model of MS. J Neurol Sci. 2009;282:34-38.
23. Ge Y, Zohrabian VM, Grossman RI. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol. 2008;65:812-816.
24. Filippi M, Agosta F. Closing the clinical-imaging gap in multiple sclerosis? Imaging iron deposition in deep gray matter. J Neuroimaging. 2009;19:1-2.
25. Stankiewicz J, Panter SS, Neema M, et al. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics. 2007;4:371-386.